GoodRx Holdings (GDRX) Current Assets (2019 - 2026)

GoodRx Holdings has disclosed Current Assets across 8 years of filings, most recently posting $1.3 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $1.3 billion, up 134.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 134.44% YoY), and the FY2025 annual result was $643.1 million, down 2.45% from the prior year.
• Current Assets came in at $1.3 billion for Q1 2026 at GoodRx Holdings, up from $643.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.3 billion in Q1 2026 to a low of $540.2 million in Q1 2025.
• The 5-year median for Current Assets is $872.8 million (2023), against an average of $805.3 million.
• Across the five-year window, Current Assets slumped 35.32% in 2024 and soared 134.44% in 2026, its largest moves.
• GoodRx Holdings' Current Assets stood at $919.7 million in 2022, then declined by 5.1% to $872.8 million in 2023, then decreased by 24.47% to $659.3 million in 2024, then retreated by 2.45% to $643.1 million in 2025, then surged by 96.93% to $1.3 billion in 2026.
• The last three Current Assets figures came in at $1.3 billion (Q1 2026), $643.1 million (Q4 2025), and $565.5 million (Q3 2025), per Business Quant data.